SEARCH

SEARCH BY CITATION

References

  • 1
    Lau JYN, Wright TL. Molecular virology and pathogenesis of hepatitis B. Lancet 1993; 342: 13351340.
  • 2
    Wright TL, Lau JYN. Clinical aspects of hepatitis B virus infection. Lancet 1993; 342: 13401344.
  • 3
    Huang SN, Chisari FV. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology 1995; 21: 620626.
  • 4
    Guidotti LG, Martinez V, Loh YT, Rogler CE, Chisari FV. Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice. J Virol 1994; 68: 54695475.
  • 5
    Mason WS, Seal G, Summers J. Virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus. J Virol 1980; 36: 829836.
  • 6
    Wu GY, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 1987; 262: 44294432.
  • 7
    Wu GY, Wu CH. Evidence for targeted gene delivery to Hep G2 hepatoma cells in vitro. Biochemistry 1988; 27: 887892.
  • 8
    Wu GY, Wu CH. Receptor-mediated gene delivery and expression in vivo. J Biol Chem 1988; 263: 1462114624.
  • 9
    Wu GY, Wu CH. Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides. J Biol Chem 1992; 267: 1243612439.
  • 10
    Schwartz AL, Fridovich SE, Knowles BB, Lodish HF. Characterization of the asialoglycoprotein receptor in a continuous hepatoma line. J Biol Chem 1981; 256: 88788881.
  • 11
    Liang TJ, Makdisi WJ, Sun S, Hasegawa K, Zhang Y, Wands JR, et al. Targeted transfection and expression of hepatitis B viral DNA in human hepatoma cells. J Clin Invest 1993; 91: 12411246.
  • 12
    Wu GY, Wu CH. Delivery systems for gene therapy. Biotherapy 1991; 3: 8795.
  • 13
    Wilson JM, Grossman M, Wu CH, Chowdhury NR, Wu GY, Chowdhury JR. Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits. J Biol Chem 1992; 267: 963967.
  • 14
    Cristiano RJ, Smith LC, Woo SL., Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc Natl Acad Sci U S A 1993; 90: 21222126.
  • 15
    Chowdhury NR, Wu CH, Wu GY, Yemeni PC, Bommineni VR, Chowdhury JR. Fate of DNA targeted to the liver by asiologlycoprotein receptor-mediated endocytosis in vivo. J Biol Chem 1993; 268: 1126511271.
  • 16
    Curiel DT, Agarwal S, Wagner E, Gotten M. Adenovirus enhancement of transferrin-polylysine—mediated gene delivery. Proc Natl Acad Sci USA 1991; 88: 88508854.
  • 17
    Wagner E, Plank C, Zatloukal K, Gotten M, Birnsliel ML., Influenza virus hemagglutinine HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci U S A 1992; 89: 79347938.
  • 18
    Cotten M, Wagner E, Zatloukal K, Birnstiel ML. Chicken adenovirus (CELO virus) particles augment receptor-mediated DNA delivery to mammalian cells and yield exceptional levels of stable transformants. J Virol 1993; 67: 37773785.
  • 19
    Condreay LD, Aldrich CE, Coates L, Mason WS, Wu TT. Efficient duck hepatitis B virus production by an avian liver tumor cell line. J Virol 1990; 64: 32493258.
  • 20
    Kawaguchi T, Nomura K, Hirayama Y, Kitagawa T. Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH. Cancer Res 1987; 47: 44604464.
  • 21
    Graham FL, Prevec L. Manipulation of adenovirus vectors. Methods Mol Biol 1991; 7: 109128.
  • 22
    Graham FL, Smiley G, Russell WC, Nairn R. Characterization of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 1977; 36: 5972.
  • 23
    Lemay P, Boudin M-L, Milleville M, Boulanger P. Human adenovirus type 2 protein IIIa. I. Purification and characterization. Virology 1980; 101: 131143.
  • 24
    Lim K, Chae C. A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for β-galactosidase. Biotechniques 1989; 7: 576579.
  • 25
    Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Ed 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
  • 26
    Bradford MM. A rapid and sensitive method for the quantitation of micro-gram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248254.
  • 27
    Mellow TE, Halberg D, Drickamer K. Endocytosis of N-acetylglucos-amine—containing glycoproteins by rat fibroblasts expressing a single species of chicken liver glycoprotein receptor. J Biol Chem 1988; 263: 54685473.
  • 28
    Verrey F, Gilbert T, Mellow T, Prouxl G, Drickamer K. Endocytosis via coated pits mediated by glycoprotein receptor in which the cytoplasmic tail is replaced by unselected sequences. Cell Regul 1990; 1: 471486.
  • 29
    Blum HE, Galun E, Liang TJ, von Weizsäcker F, Wands JR. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991; 65: 18361842.
  • 30
    Staros JV, Wright RW, Swingle DM. Enhancement by N-hydroxysulfosuc-cinimide of water-soluble carbodiimide-mediated coupling reactions. Anal Biochem 1986; 16: 220222.
  • 31
    Wagner E, Zatloukal K, Cotten M, Kirlappos H, Mechtler K, Curièl DT, Birnstiel ML. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci U S A 1992; 89: 60996103.
  • 32
    Grossman M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Müller D, Lupien PJ, et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet 1994; 6: 335341.
  • 33
    Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman C, Finegold M, et al. In vivo gene therapy of hepatitis B: sustained partial correction in factor IX-deficient dogs. Science 1993; 262: 117119.
  • 34
    Rettinger SD, Kennedy SC, Wu X, Saylors RL, Hafenrichter DG, Flye MW, Ponder KP. Liver-directed gene therapy: quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc Natl Acad Sci U S A 1994; 91: 14601464.
  • 35
    Branchereau S, Calise D, Ferry N. Factors influencing retroviral-mediated gene transfer into hepatocytes in vivo. Hum Gene Ther 1994; 5: 803808.
  • 36
    Rensen PCN, Vandijk MCM, Havenaar EC, Bijsterbosch MK, Kruijt JK, Vanberkel TJC. Selective liver targeting of antivirals by recombinant chy-lomicrons: a new therapeutic approach to hepatitis B. Nat Med 1995; 1: 221225.
  • 37
    Lieber A, Vrancken Peeters M-J, Meuse L, Fausto N, Perkins J, Kay MA. Adenovirus-mediated urokinase gene transfer induces liver regeneration and allows for efficient retrovirus transduction of hepatocytes in vivo. Proc Natl Acad Sci U S A 1995; 92: 62106214.
  • 38
    Offensperger WB, Offensperger S, Walter E, Teubner K, Igloi G, Blum HE, Gerok W. In vivo inhibition of duck hepatitis B virus replication and gene expression by phosphorothioate modified antisense oligodeoxynucleo-tides. EMBO J 1993; 12: 12571262.
  • 39
    McCray PB, Armstrong K, Labner J, Miller DW, Koretzky GA, Couture L, Robillard JE, et al. Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J Clin Invest 1995; 95: 26202632.